Kura Oncology Officer Proposes Sale of 4,607 Shares

A Rule 144 notice names Kura Oncology, Inc. (KURA) as the issuer and identifies Officer Thomas James Doyle for a proposed sale of 4,607 shares of common stock, with an aggregate market value of $49,571.32 and an approximate sale date of September 28, 2026.

Rhea-AI Filing Summary

A Rule 144 notice names Kura Oncology, Inc. (KURA) as the issuer and identifies Officer Thomas James Doyle for a proposed sale of 4,607 shares of common stock, with an aggregate market value of $49,571.32 and an approximate sale date of September 28, 2026. The shares are listed as acquired from the issuer as PSUs on September 27, 2026; Morgan Stanley Smith Barney LLC is named in the broker field. Teresa Bair signed as attorney-in-fact for Thomas Doyle.

Key Figures

Shares in proposed sale: 4,607 shares Aggregate market value: $49,571.32 Common shares outstanding: 91,869,597 shares +2 more

5 metrics

Shares in proposed sale 4,607 shares Kura Oncology common stock

Aggregate market value $49,571.32 Proposed sale

Common shares outstanding 91,869,597 shares Kura Oncology common stock

Approximate sale date September 28, 2026 Proposed sale

Acquisition date September 27, 2026 Shares listed as acquired from the issuer as PSUs

Key Terms

Rule 144, PSU, aggregate market value

3 terms

Rule 144 regulatory

"Rule 144 notice"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

PSU financial

"PSU"

A PSU is a company where the government owns a controlling stake and often plays a direct role in its management and strategy. Think of it like a business that operates with public oversight, similar to a town-run utility versus a private neighborhood service. Investors watch PSUs differently because government involvement can affect profits, dividend policies, regulatory treatment and stability, so these stocks may behave more like policy instruments than pure market-driven enterprises.

aggregate market value financial

"aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares does Thomas James Doyle's Rule 144 notice cover?

The notice lists a proposed sale of 4,607 shares of Kura Oncology common stock, with an aggregate market value of $49,571.32 and an approximate sale date of September 28, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 08:00 PM Accepted by SEC EDGAR 09/28/2026 - 08:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001910331
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KURA ONCOLOGY, INC.
SEC File Number	001-37620
Address of Issuer	4930 Directors Place, Suite 500 San Diego CALIFORNIA 92121
Phone	(858)-500-8800
Name of Person for Whose Account the Securities are To Be Sold	DOYLE THOMAS JAMES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4607	49571.32	91869597	09/28/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/27/2026	PSU	Issuer			4607	09/28/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Teresa Bair, Attorney-in-fact for Thomas Doyle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)